Eledon Pharmaceuticals, Inc.

Q1 2026 13F Holders

Symbol
ELDN
CUSIP
28617K101
Type
Equity
Class
COM
Num filings
124
Total reported value, excl. options
$131 M
Manager Report Date Value ($000) Shares Option Type